The initial treatment of Parkinson's disease
Author:
- Stewart A. FactorSFStewart A. Factor
- 1 March 2000
- journal article
- letter
- Published by Wiley in Movement Disorders
- Vol. 15 (2) , 360-361
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The initial treatment of Parkinson's disease should begin with levodopaMovement Disorders, 1999
- Treatment of Parkinson's disease should begin with a dopamine agonistMovement Disorders, 1999
- Dopamine-Receptor Subtype-Selective Agonists in the Treatment of Parkinsonʼs DiseaseClinical Neuropharmacology, 1995
- The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's diseaseMovement Disorders, 1994
- Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's diseaseNeurology, 1993
- Early combination therapy with bromocriptine and levodopa in parkinson's diseaseMovement Disorders, 1993
- Nation-Wide Collaborative Study on the Long-Term Effects of Bromocriptine in the Treatment of Parkinsonian Patients: Final ReportEuropean Neurology, 1992
- To treat early or to treat late?Annals of Neurology, 1987
- Early combination of bromocriptine and levodopa in the treatment of Parkinson's diseaseNeurology, 1987